Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MRI may offer Radiation-Free diagnosis for lung fungal allergy

NCT ID NCT03265366

First seen May 21, 2026 · Last updated Jun 22, 2026 · Updated 4 times

Summary

This study tested whether MRI can accurately detect lung abnormalities caused by allergic bronchopulmonary aspergillosis (ABPA), a fungal allergy. Researchers compared MRI results to standard CT scans in 25 adults with ABPA or severe asthma. If MRI works well, it could provide a safer, radiation-free way to diagnose and monitor ABPA.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux

    Pessac, 33604, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If MRI proves accurate, it could offer a radiation-free alternative to CT scans for diagnosing ABPA.

What could go wrong

This is a small, completed study with only 25 participants, so results may not apply to everyone. MRI might not detect all signs of ABPA as well as CT scans.

Conditions

The condition(s) this trial relates to.

allergic bronchopulmonary aspergillosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.